Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGFR | P43088 | 17/20 | 0.58 |
| ▸ | PTGER3 | P43115 | 4/20 | 0.58 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.47 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.47 |
| ▸ | TBXA2R | P21731 | 3/20 | 0.43 |
| ▸ | PTGER1 | P34995 | 2/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1043901 | 1.00 | PTGFR (0.58) | PTGFRPTGER3ABCC4ABCB11TBXA2R | |
| SCHEMBL1043898 | 1.00 | PTGFR (0.58) | PTGFRPTGER3ABCC4ABCB11TBXA2R | |
| SCHEMBL1043903 | 1.00 | PTGFR (0.58) | PTGFRPTGER3ABCC4ABCB11TBXA2R | |
| SCHEMBL1044517 | 0.90 | PTGFR (0.48) | PTGFRPTGER3ABCC4ABCB11THRB | |
| SCHEMBL1044516 | 0.90 | PTGFR (0.48) | PTGFRPTGER3ABCC4ABCB11THRB | |
| SCHEMBL1044518 | 0.90 | PTGFR (0.48) | PTGFRPTGER3ABCC4ABCB11THRB | |
| SCHEMBL1460919 | 0.90 | PTGFR (0.48) | PTGFRPTGER3ABCC4ABCB11THRB | |
| SCHEMBL1047178 | 0.90 | PTGFR (0.60) | PTGFRPTGER3ABCC4ABCB11TBXA2R | |
| SCHEMBL1043819 | 0.90 | PTGFR (0.47) | PTGFRPTGER3ABCC4ABCB11 | |
| SCHEMBL1460588 | 0.90 | PTGFR (0.47) | PTGFRPTGER3ABCC4ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011032159-A1 | METHODS TO PREVENT A HAIR-RELATED SIDE EFFECT OF TREATMENT WITH A CHEMOTHERAPEUTIC AGENT | META COMESTICS, LLC (US) | 2011-03-17 | — | — | WO | disclosed |